A detailed history of Neuberger Berman Group LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Neuberger Berman Group LLC holds 9,347 shares of JAZZ stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,347
Previous 7,217 29.51%
Holding current value
$1.15 Million
Previous $770,000 35.19%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.57 - $116.37 $214,214 - $247,868
2,130 Added 29.51%
9,347 $1.04 Million
Q2 2024

Nov 14, 2024

SELL
$103.94 - $118.98 $13,824 - $15,824
-133 Reduced 1.81%
7,217 $770,000
Q2 2024

Aug 13, 2024

SELL
$103.94 - $118.98 $13,824 - $15,824
-133 Reduced 1.81%
7,217 $770,000
Q1 2024

Nov 14, 2024

BUY
$115.19 - $132.77 $69,229 - $79,794
601 Added 8.91%
7,350 $885,000
Q1 2024

May 13, 2024

BUY
$115.19 - $132.77 $846,646 - $975,859
7,350 New
7,350 $885,000
Q4 2023

Nov 14, 2024

SELL
$114.26 - $136.0 $53,473 - $63,648
-468 Reduced 6.48%
6,749 $830,000
Q4 2023

Feb 09, 2024

SELL
$114.26 - $136.0 $31,535 - $37,536
-276 Reduced 3.93%
6,749 $830,000
Q3 2023

Nov 14, 2023

BUY
$122.0 - $145.31 $153,598 - $182,945
1,259 Added 21.83%
7,025 $909,000
Q2 2023

Aug 11, 2023

BUY
$122.5 - $147.16 $180,810 - $217,208
1,476 Added 34.41%
5,766 $714,000
Q1 2023

May 12, 2023

BUY
$133.98 - $160.47 $63,774 - $76,383
476 Added 12.48%
4,290 $627,000
Q4 2022

Feb 13, 2023

SELL
$129.72 - $159.85 $11,415 - $14,066
-88 Reduced 2.26%
3,814 $607,000
Q3 2022

Nov 15, 2022

SELL
$126.59 - $161.18 $76,713 - $97,675
-606 Reduced 13.44%
3,902 $520,000
Q2 2022

Aug 15, 2022

SELL
$141.59 - $168.66 $95,998 - $114,351
-678 Reduced 13.07%
4,508 $704,000
Q1 2022

May 13, 2022

BUY
$129.64 - $160.7 $227,518 - $282,028
1,755 Added 51.15%
5,186 $782,000
Q4 2021

Feb 11, 2022

BUY
$119.87 - $145.67 $169,616 - $206,123
1,415 Added 70.19%
3,431 $416,000
Q3 2021

Nov 12, 2021

BUY
$128.64 - $184.79 $2,058 - $2,956
16 Added 0.8%
2,016 $243,000
Q2 2021

Aug 13, 2021

BUY
$160.2 - $186.42 $11,694 - $13,608
73 Added 3.79%
2,000 $330,000
Q1 2021

May 13, 2021

SELL
$150.19 - $173.5 $13,366 - $15,441
-89 Reduced 4.41%
1,927 $293,000
Q4 2020

Feb 10, 2021

BUY
$140.71 - $165.05 $10,131 - $11,883
72 Added 3.7%
2,016 $322,000
Q3 2020

Nov 12, 2020

SELL
$105.46 - $144.13 $6.79 Million - $9.28 Million
-64,414 Reduced 97.07%
1,944 $277,000
Q2 2020

Aug 13, 2020

BUY
$95.68 - $121.88 $1.91 Million - $2.44 Million
20,004 Added 43.15%
66,358 $7.32 Million
Q1 2020

May 14, 2020

SELL
$87.74 - $152.74 $439,050 - $764,310
-5,004 Reduced 9.74%
46,354 $4.62 Million
Q4 2019

Feb 12, 2020

BUY
$117.65 - $153.73 $6.04 Million - $7.9 Million
51,358 New
51,358 $7.67 Million
Q1 2019

May 13, 2019

SELL
$121.81 - $142.95 $342,773 - $402,261
-2,814 Closed
0 $0
Q4 2018

Feb 12, 2019

SELL
$115.94 - $166.74 $12.4 Million - $17.8 Million
-106,988 Reduced 97.44%
2,814 $349,000
Q3 2018

Nov 13, 2018

SELL
$161.01 - $180.57 $23,024 - $25,821
-143 Reduced 0.13%
109,802 $18.5 Million
Q2 2018

Aug 13, 2018

SELL
$146.33 - $183.18 $1.08 Million - $1.36 Million
-7,400 Reduced 6.31%
109,945 $18.9 Million
Q3 2017

Nov 15, 2017

BUY
$142.62 - $155.6 $16.7 Million - $18.3 Million
117,345
117,345 $17.2 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.69B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.